All In MedTech

Device Trial Radar · NCT07121933

Evaluation of Erchonia PPL Laser as a Pretreatment Adjunct to Enhance Standard Erchonia Red Laser for the Relief of Pain

An Evaluation of The Erchonia® PPL Laser as a Pre-Treatment Adjunct to Enhance Standard Erchonia Red Laser Therapy for the Temporary Relief of Nociceptive Musculoskeletal Pain

Last checked: Nov 20, 2026Latest source record: Jun 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

44

Actual

Start

Aug 20, 2025

Primary completion

Mar 26, 2026

Study completion Mar 28, 2026

Sponsor

Lead sponsor
Erchonia CorporationNot on our public-company list
Sponsor type
Industry
First posted
Aug 14, 2025

More device trials from this sponsor

Design

Study type
Interventional
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is to see if applying pre-treatment with the Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapy can help reduce nociceptive musculoskeletal pain

Conditions

  • Musculoskeletal Pain

Interventions

  • Erchonia® PPL blue laser therapy, followed sequentially with the standard Erchonia red laser therapyDevice

    450 nanometers (nm) blue dual-diode laser application followed by 640nm red laser application

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Subjects With 30% or Greater Change in Pain Rating on the Visual Analog Scale (VAS)Time frame: Day 1

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Laser Chiropractic

    West Covina, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.